Literature DB >> 4372614

Reciprocal inhibition of mouse leukemia virus infection by Fv-1 allele cell extracts.

R W Tennant, B Schluter, W Yang, A Brown.   

Abstract

Soluble extracts of mouse cells with Fv-1(n) or Fv-1(b) gene alleles specifically and reciprocally inhibit infection of B- or N-tropic mouse leukemia viruses in permissive cell cultures. NB-tropic virus infection was not inhibited by either cell extract. Extracts from Fv-1(-) cells did not inhibit infection by the three virus host-range types, but N- or B-tropic virus infection of Fv-1(-) cells was inhibited by extracts of the nonpermissive cells, and Fv-1(nb) cell extracts inhibited both viruses. The maximum degree of inhibition was 50-80% as determined by immunofluorescent or plaque assays, with extracts containing up to 500 mug/ml of nonpermissive cell protein. The inhibitor(s) is relatively unstable since activity is lost after 2 hr at 37 degrees or 30 min at 56 degrees . The inhibitor(s) was most effective if added 2 hr before or within 2 hr after infection, did not react with the virus directly, inhibit virus attachment, or inhibit the normal cell functions tested. These results indicate that nonpermissive mouse cells contain a product, possibly determined by the Fv-1 gene, which inhibits some early postpenetration event(s) in leukemia virus infection.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4372614      PMCID: PMC434367          DOI: 10.1073/pnas.71.10.4241

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Requirement of cellular DNA synthesis for the growth of Friend leukemia virus.

Authors:  H Yoshikura
Journal:  Exp Cell Res       Date:  1968-10       Impact factor: 3.905

2.  Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

3.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

4.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

5.  Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.

Authors:  D R Lowy; W P Rowe; N Teich; J W Hartley
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

6.  Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells.

Authors:  S A Aaronson; G J Todaro; E M Scolnick
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

7.  Genetic factors influencing C-type RNA virus induction.

Authors:  J R Stephenson; S A Aaronson
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

8.  A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus.

Authors:  T Pincus; W P Rowe; F Lilly
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

9.  Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1 b strains of mice.

Authors:  W P Rowe; J W Hartley
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

10.  A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses.

Authors:  T Pincus; J W Hartley; W P Rowe
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  11 in total

1.  Transfection of Fv-1 permissive and restrictive mouse cells with integrated DNA of murine leukemia viruses.

Authors:  I C Hsu; W K Yang; R W Tennant; A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells.

Authors:  W K Yang; J O Kiggans; D M Yang; C Y Ou; R W Tennant; A Brown; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

3.  Transfer of Fv-1 locus-specific resistance to murine N-tropic and B-tropic retroviruses by cytoplasmic RNA.

Authors:  W K Yang; R W Tennant; R J Rascati; J A Otten; B Schluter; J O Kiggans; F E Myer; A Brown
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

4.  Fv-1 host restriction of Friend leukemia virus: analysis of unintegrated proviral DNA.

Authors:  J Chinsky; R Soeiro
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

5.  Host restriction of Friend Leukemia virus coat protein synthesis.

Authors:  U Ray; R Soeiro; B N Fields
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

6.  Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus.

Authors:  P Jolicoeur; E Rassart
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Six-NB-tropic murine leukemia viruses derived from a B-tropic virus of BALB/c have altered p30.

Authors:  N Hopkins; J Schindler; R Hynes
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

8.  Genetic evidence for a product of the Fv-1 locus that transfers resistance to mouse leukemia viruses.

Authors:  R W Tennant; B Schluter; F E Myer; J A Otten; W K Yang; A Brown
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

9.  Fate of unintegrated viral DNA in Fv-1 permissive and resistant mouse cells infected with murine leukemia virus.

Authors:  P Jolicoeur; E Rassart
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

10.  A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.

Authors:  Nidia M M Oliveira; Roochi Trikha; Áine McKnight
Journal:  Retrovirology       Date:  2010-10-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.